EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis: Results from the pooled data of the Maximal Individual Therapy in acute myocardial infarction (MITRA) registry and the Myocardial Infarction Registry (MIR)



Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis: Results from the pooled data of the Maximal Individual Therapy in acute myocardial infarction (MITRA) registry and the Myocardial Infarction Registry (MIR)



Journal of the American College of Cardiology 36(7): 2064-2071



OBJECTIVES: We investigated changes in the clinical outcome of primary angioplasty and thrombolysis for the treatment of acute myocardial infarction (AMI) from 1994 to 1998. BACKGROUND: Primary angioplasty for the treatment of AMI is a sophisticated technical procedure that requires experienced personnel and optimized hospital logistics. Growing experience with primary angioplasty in clinical routine and new adjunctive therapies may have improved the outcome over the years. METHODS: The pooled data of two German AMI registries: the Maximal Individual Therapy in AMI (MITRA) study and the Myocardial Infarction Registry (MIR) were analyzed. RESULTS: Of 10,118 lytic eligible patients with AMI, 1,385 (13.7%) were treated with primary angioplasty, and 8,733 (86.3%) received intravenous thrombolysis. Patients characteristics were quite balanced between the two treatment groups, but there was a higher proportion of patients with a prehospital delay of >6 h in those treated with primary angioplasty. The proportion of an in-hospital delay of more than 90 min significantly decreased in patients treated with primary angioplasty over the years (p for trend = 0.015, multivariate odds ratio (OR) for each year of the observation period = 0.84, 95% confidence interval (CI): 0.73-0.96) but did not change significantly in patients treated with thrombolysis. Hospital mortality decreased significantly in the primary angioplasty group (p = 0.003 for trend; multivariate OR for each year = 0.73, 95% CI: 0.58- 0.93). However, for patients treated with thrombolysis, hospital mortality did not change significantly (p for trend 0.175, multivariate OR for each year: 1.02, 95% CI: 0.94- 1.11). CONCLUSIONS: Compared with thrombolysis the clinical results of primary angioplasty for the treatment of AMI improved from 1994 to 1998. This indicates a beneficial effect of the growing experience and optimized hospital logistics of this technique over the years.

(PDF emailed within 0-6 h: $19.90)

Accession: 010419942

Download citation: RISBibTeXText

PMID: 11127442

DOI: 10.1016/s0735-1097(00)00981-5



Related references

Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis Results from the pooled data of the Maximal Individual Therapy in acute myocardial infarction registry and the Myocardial Infarction Registry. Journal of the American College of Cardiology 36(7): 2064-2071, December, 2000

Primary angioplasty versus no reperfusion therapy in patients with acute myocardial infarction and a pre-hospital delay of > 12-24 hours: results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR). Journal of Invasive Cardiology 13(5): 367-372, 2001

Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: Can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute myocardial infarction registry and the Myocardial Infarction Registry. Journal of the American College of Cardiology 37(7): 1827-1835, June 1, 2001

Primary angioplasty vs. intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the maximal individual therapy in acute myocardial infarction registry and the myocardial infarction registry. Acc Current Journal Review 10(6): 17-18, 2001

Transfer of patients with acute myocardial infarction for primary or acute angioplasty from hospitals without the facilities to perform angioplasty. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR). Herz 25(7): 667-675, 2001

Transfer of patients with acute myocardial infarction for primary or acute angioplasty from hospitals without the facilities to perform angioplasty. Results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR). Herz 25(7): 667-675, 2000

Transfer of patients with acute myocardial infarction for primary or acute angioplasty from hospitals without the facilities to perform angioplasty Results from the pooled data of the maximal individual therapy in acute myocardial infarction registry and the myocardial infarction registry. Herz 25(7): 667-675, November, 2000

Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results from the pooled data of the maximal individual therapy in acute myocardial infarction [MITRA], and the myocardial infarction registry [MIR]). American Journal of Cardiology 87(9): 1039-1044, 2001

Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA), and the Myocardial Infarction Registry (MIR)). American Journal of Cardiology 87(9): 1039-1044, 2001

Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology: results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA 1 & 2) registries and the myocardial infarction registry (MIR). Acc Current Journal Review 11(2): 16-0, 2002

Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology; results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA 1+2) Registries and the Myocardial Infarction Registry (MIR). European Heart Journal 22(19): 1794-1801, 2001

In-hospital mortality of elderly patients with acute myocardial infarction: Data from the MITRA (Maximal Individual Therapy in Acute Myocardial Infarction) registry. Clinical Cardiology 23(11): 831-836, 2000

Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Circulation 102(18 Supplement): II 385, October 31, 2000

Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction registries and the Myocardial Infarction Registry. European Heart Journal 22(19): 1794-1801, October, 2001

Time of in-hospital death in patients with Acute Myocardial Infarction treated with primary angioplasty compared to patients treated with intravenous thrombolysis Results from the pooled data of the MITRA and the MIR Registries. Journal of the American College of Cardiology 37(2 Supplement A): 372A, February, 2001